Search For "drugs controller general of india"
DCGI issues guidelines for pharma giants manufacturing COVID-19 vaccine
Updated : 5 years, 5 months ago IST
New Delhi [India], September 23 (ANI): The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
Read More
First cost, time-effective CRISPER test for Covid-19 gets nod for commerc
Updated : 5 years, 6 months ago IST
New Delhi [India], September 20 (ANI): The Drugs Controller General of India (DCGI) has given approval to the Tata Group for the launch of India's first Clustered Regularly Interspaced Short Palindromic (CRISPR) Covid-19 test for commercial launch.
Read More
DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19
Updated : 5 years, 6 months ago IST
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
Read More
Serum Institute to resume COVID-19 vaccine trials in India after DCGI nod
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
Read More
DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
Read More
Serum Institute says will adhere to DCGI instructions after show cause ove
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a show-cause notice Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about
Read More
Serum Institute initiates phase 2, 3 clinical study on 1,600 volunteers fo
Updated : 5 years, 7 months ago IST
New Delhi [India], August 19 (ANI): Indian pharmaceutical giant Serum Institute of India has initiated the phase 2, 3 clinical trials to evaluate the safety and immune response of coronavirus vaccine candidate on healthy Indian adults after the pharma company got approval from Drugs Controll
Read More
Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment
Updated : 5 years, 7 months ago IST
Hyderabad (Telangana) [India], Aug 19 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets in India for treatment of patients with mild to moderate COVID-19 disease.
Read More
DGCI nod for Apheresis machine to extract blood plasma in Goa
Updated : 5 years, 7 months ago IST
Panaji (Goa) [India], Aug 4 (ANI): Goa has made a new breakthrough in its plasma therapy for critically ill COVID-19 patients after Drugs Controller General of India (DGCI) gave its approval for using Apheresis machine to extract blood plasma, said Health Minister Vishwajit P Rane.
Read More
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine tria
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on
Read More
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in
Updated : 5 years, 7 months ago IST
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Read More
COVID-19: Health Ministry directs DCGI to ensure equitable distribution of
Updated : 5 years, 7 months ago IST
New Delhi [India], July 29 (ANI): The Union Health and Family Welfare Ministry has directed the Drugs Controller General of India (DCGI) to ensure equitable distribution of drugs across the country included as part of "investigational therapies" in clinical management protocol for COVID-19.
Read More